Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Molecular Pathways in Pancreatic Ductal Adenocarcinomas with a Bioinformatics Approach

  • Wang, Yan (Department of Gastroenterology, Shengjing Hospital of China Medical University) ;
  • Li, Yan (Department of Gastroenterology, Shengjing Hospital of China Medical University)
  • Published : 2015.04.03
Download PDF
⟨ Previous Next ⟩

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death worldwide. Our study aimed to reveal molecular mechanisms. Microarray data of GSE15471 (including 39 matching pairs of pancreatic tumor tissues and patient-matched normal tissues) was downloaded from Gene Expression Omnibus (GEO) database. We identified differentially expressed genes (DEGs) in PDAC tissues compared with normal tissues by limma package in R language. Then GO and KEGG pathway enrichment analyses were conducted with online DAVID. In addition, principal component analysis was performed and a protein-protein interaction network was constructed to study relationships between the DEGs through database STRING. A total of 532 DEGs were identified in the 38 PDAC tissues compared with 33 normal tissues. The results of principal component analysis of the top 20 DEGs could differentiate the PDAC tissues from normal tissues directly. In the PPI network, 8 of the 20 DEGs were all key genes of the collagen family. Additionally, FN1 (fibronectin 1) was also a hub node in the network. The genes of the collagen family as well as FN1 were significantly enriched in complement and coagulation cascades, ECM-receptor interaction and focal adhesion pathways. Our results suggest that genes of collagen family and FN1 may play an important role in PDAC progression. Meanwhile, these DEGs and enriched pathways, such as complement and coagulation cascades, ECM-receptor interaction and focal adhesion may be important molecular mechanisms involved in the development and progression of PDAC.

Keywords

References

  1. Apte M, Park S, Phillips P, et al (2004). Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas, 29, 179-87. https://doi.org/10.1097/00006676-200410000-00002
  2. Ashburner M, Ball CA, Blake JA, et al (2000). Gene ontology: tool for the unification of biology. Nature Genetics, 25, 25-9. https://doi.org/10.1038/75556
  3. Badea L, Herlea V, Dima SO, et al (2008). Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia-the authors reported a combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepato-gastroenterol, 55, 2016.
  4. Bournet B, Pointreau A, Souque A, et al (2012). Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Pancreatol, 12, 27-34. https://doi.org/10.1016/j.pan.2011.12.003
  5. Campagna D, Cope L, Lakkur SS, et al (2008). Gene expression profiles associated with advanced pancreatic cancer. Int J Clin Exp Pathol, 1, 32-43.
  6. Cassar-Malek I, Passelaigue F, Bernard C, et al (2007). Target genes of myostatin loss-of-function in muscles of late bovine fetuses. BMC genomics, 8, 63. https://doi.org/10.1186/1471-2164-8-63
  7. Dempe S, Stroh-Dege AY, Schwarz E, et al (2010). SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV. Int J Cancer, 126, 2914-27.
  8. Derrick TR, Bates BT, Dufek JS (1994). Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. Med Sci Sports Exercise, 26, 919-28.
  9. Edderkaoui M, Hong P, Lee JK, et al (2007). Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin. J Biol Chem, 282, 26646-55. https://doi.org/10.1074/jbc.M702836200
  10. Furuyama K, Doi R, Mori T, et al (2006). Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg, 30, 219-26. https://doi.org/10.1007/s00268-005-0165-z
  11. Gautier L, Cope L, Bolstad BM , Irizarry RA (2004). Affy-analysis of affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-15. https://doi.org/10.1093/bioinformatics/btg405
  12. Gelse K, Poschl E , Aigner T (2003). Collagens-structure, function, and biosynthesis. Adv Drug Delivery Reviews, 55, 1531-46. https://doi.org/10.1016/j.addr.2003.08.002
  13. Giot L, Bader J S, Brouwer C, et al (2003). A protein interaction map of Drosophila melanogaster. Science, 302, 1727-36. https://doi.org/10.1126/science.1090289
  14. Grippo PJ, Munshi HG, Rasheed ZA, et al (2012). Pathology of pancreatic stroma in PDAC. JOURNAL DETAILS
  15. Hezel AF, Kimmelman AC, Stanger BZ, et al (2006). Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev, 20, 1218-49. https://doi.org/10.1101/gad.1415606
  16. Huang DW, Sherman BT , Lempicki RA (2008). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44-57. https://doi.org/10.1038/nprot.2008.211
  17. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, et al (2003). Highly expressed genes in pancreatic ductal adenocarcinomas A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res, 63, 8614-22.
  18. Irizarry R, Hobbs B, Collin F, et al (2003). Biostatistics. Vol. 4. DETAILS Oxford, England.
  19. Ishiguro S, Yoshimura K, Takao S, et al (2014). Involvement of an angiotensin II type 2 receptor (AT2R) signalling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Res, 74, 4606-. https://doi.org/10.1158/1538-7445.AM2014-4606
  20. Jaffee E M, Hruban R H, Canto M , Kern S E (2002). Focus on pancreas cancer. Cancer Cell, 2, 25-8. https://doi.org/10.1016/S1535-6108(02)00093-4
  21. Jensen LJ, Kuhn M, Stark M, et al (2009). STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res, 37, 412-6. https://doi.org/10.1093/nar/gkn760
  22. Jiao Y, Shi C, Edil BH, et al (2011). DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science, 331, 1199-203. https://doi.org/10.1126/science.1200609
  23. Kanehisa M, Goto S (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28, 27-30. https://doi.org/10.1093/nar/28.1.27
  24. Krupp M, Maass T, Marquardt JU, et al (2011). The functional cancer map: a systems-level synopsis of genetic deregulation in cancer. BMC Medical Genomics, 4, 53. https://doi.org/10.1186/1755-8794-4-53
  25. Li D, Xie K, Wolff R , Abbruzzese JL (2004). Pancreatic cancer. Lancet, 363, 1049-57. https://doi.org/10.1016/S0140-6736(04)15841-8
  26. Lin Y, Jin Y, Lin LJ, et al (2014a). Candidate agents for pancreatic ductal adenocarcinoma identified by a sub-pathway based method. Gene, 540, 232-7. https://doi.org/10.1016/j.gene.2014.01.081
  27. Linder S (2001). Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma, 48, 1321-7.
  28. Malats N (2014). Pancreatic cancer: risk factors. Pancreatol, 14, 2. https://doi.org/10.1016/j.pan.2014.01.007
  29. Michaud D (2004). Epidemiology of pancreatic cancer. Minerva Chirurgica, 59, 99-111.
  30. Morton JP, Timpson P, Karim SA, et al (2010). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA, 107, 246-51. https://doi.org/10.1073/pnas.0908428107
  31. Moz S, Bozzato D, Galozzi P, et al (2014). Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC. Pancreatol, 14, 69.
  32. Navas C, Hernandez-Porras I, Schuhmacher A J, et al (2012). EGF receptor signaling is essential for K Ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer cell, 22, 318-30. https://doi.org/10.1016/j.ccr.2012.08.001
  33. Neuhaus P, Riess H, Post S, et al (2008). CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). J Clin Oncol, 26, 15.
  34. Ostman A , Augsten M (2009). Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Current Opinion Genetics Dev, 19, 67-73. https://doi.org/10.1016/j.gde.2009.01.003
  35. Pandol SJ, Apte MV, Wilson JS, et al (2012). The burning question: why is smoking a risk factor for pancreatic cancer? Pancreatol, 12, 344-9. https://doi.org/10.1016/j.pan.2012.06.002
  36. Rasheed ZA, Jung C, Huang A, et al (2012). Abstract A70: The extracellular matrix regulates pancreatic cancer stem cell function via focal adhesion kinase signaling. Cancer Res, 72, 70. https://doi.org/10.1158/1538-7445.AM2012-70
  37. Rawnaq T, Dietrich L, Wolters-Eisfeld G, et al (2014). The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer. Molecular Cancer Res, 12, 670-80. https://doi.org/10.1158/1541-7786.MCR-13-0467
  38. Raychaudhuri S, Stuart JM , Altman RB (2000). Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput, 2000, 455-66.
  39. Sartor I, Zeidan-Chulia F, Albanus R, et al (2014). Computational analyses reveal a prognostic impact of TULP3 as a transcriptional master regulator in pancreatic ductal adenocarcinoma. Molecular BioSystems, 10, 1461-8. https://doi.org/10.1039/c3mb70590k
  40. Schwarz R E, Awasthi N, Konduri S, et al (2010). Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation. Cancer Biology Therapy, 9, 632-9. https://doi.org/10.4161/cbt.9.8.11265
  41. Shi B, Wang X, Han X, et al (2014). Functional modules analysis based on coexpression network in pancreatic ductal adenocarcinoma. Pathol Oncol Res, 20, 293-9. https://doi.org/10.1007/s12253-013-9694-1
  42. Smyth G K (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3, 3.
  43. Stenzel D, Lundkvist A, Sauvaget D, et al (2011). Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Dev, 138, 4451-63. https://doi.org/10.1242/dev.071381
  44. Tusher V G, Tibshirani R , Chu G (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA, 98, 5116-21. https://doi.org/10.1073/pnas.091062498
  45. Vaquero EC, Edderkaoui M, Nam KJ, et al (2003). Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. Gastroenterol, 125, 1188-202. https://doi.org/10.1016/S0016-5085(03)01203-4
  46. Whitcomb DC, Gorry MC, Preston RA, et al (1996). Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genetics, 14, 141-5. https://doi.org/10.1038/ng1096-141
  47. Zhao LL, Zhang T, Liu BR, et al (2014). Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level. Molecular biol Rep, 41, 2875-83. https://doi.org/10.1007/s11033-014-3143-4

Cited by

  1. In silico docking of methyl isocyanate (MIC) and its hydrolytic product (1, 3-dimethylurea) shows significant interaction with DNA Methyltransferase 1 suggests cancer risk in Bhopal-Gas-Tragedy survivors vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7663
  2. Expression and influence of Notch signaling in oral squamous cell carcinoma vol.58, pp.2, 2016, https://doi.org/10.2334/josnusd.15-0535
  3. Network-based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer pp.08991987, 2018, https://doi.org/10.1002/mc.22920